The volatile content of the exhaled breath gas of mamma carcinoma patients will be chemically analyzed by proton-transfer-reaction time of flight mass spectrometry. The goal of the study is to determine typical breath gas components that allow to distinguish patients with mamma carcinoma from women without carcinoma. Further, the investigators will test whether these breath gas markers can be used as tumor markers, which change in a typical manner during the progress of the disease. Finally the data will be investigated for the presence of marker components, that identify patients who will develop metastasis.
Study Type
OBSERVATIONAL
Enrollment
202
Collect two breath gas samples per patient on one day before surgery
Collect two or more breath gas samples on different days during adjuvant or neo-adjuvant therapy.
Department of Gynecology and Obstetrics, Medical University Innsbruck
Innsbruck, Tyrol, Austria
Breath gas markers
Breath gas markers that allow to distinguish patients with mamma carcinoma from women without carcinoma;
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.